Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Sparsentan, the Dual Endothelin Angiotensin Receptor Antagonist (DEARA), Improves Kidney Function and Life Span and Protects Against Hearing Loss in Alport Mice with Developed Renal Structural Changes

Dominic E. Cosgrove, MichaelAnne Gratton, Daniel T. Meehan, Denise Vosik, Jacob D. Madison, Duane C. Delimont, Gina C. Samuelson, Diana Jarocki, Radko Komers, Celia P. Jenkinson, "Sparsentan, the Dual Endothelin Angiotensin Receptor Antagonist (DEARA), Improves Kidney Function and Life Span and Protects Against Hearing Loss in Alport Mice with Developed Renal Structural Changes", Am. Soc. Nephrol. Kidney Week Abstract Supplement: PO1299 2021.